Dublin, Feb. 08, 2019 (GLOBE NEWSWIRE) -- The "Blood Stream Infection Testing - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering. Global Blood Stream Infection Testing Market is expected to grow at a CAGR of 8.9% during the forecast period. Some of the factors such as rise in prevalence of infections such as abdominal infections, dental infections and increase in occurrence geriatric population are fueling the market growth. However, strict government rules associated to the safety and efficacy is limiting the market growth. Blood Stream Infection testing market provides ample opportunities to ongoing R&D activities in various countries across the globe. Blood stream infection is a condition in which bacterial, fungal, or any infection is detected in the blood. It normally arises when infection in any part of body enters the blood stream and this infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult due to its regular symptoms such as chills, fever, diarrhea, vomiting. As a result, testing is mandatory for detection of infection in blood. Amongst End User, Hospital Laboratories segment accounted held significant market share during the forecast period. The healthcare industry is steadily adopting automated solutions to diminish the cost incurred on staffing and to produce accurate results. Also, automated solutions aid healthcare professionals in reducing the time taken for manually intensive tasks. This allows researchers to focus extensively on patient consultation and precision in diagnosis and improving productivity. By geography, North America dominated the market during the forecast period due to the factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region. What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered: 1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.5 Research Sources 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Product Analysis 3.7 Technology Analysis 3.8 Application Analysis 3.9 End User Analysis 3.10 Emerging Markets 3.11 Futuristic Market Scenario 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Blood Stream Infection Testing Market, By Test Type 5.1 Introduction 5.2 Conventional Blood Culture Tests 5.3 Blood Gases 5.4 Complete Blood Count (CBC) 5.5 Culture of Skin Sore 5.6 Cerebrospinal Fluid (CSF) Culture 5.7 Platelet Count 5.8 Urine Culture 5.9 Chest X-Ray 5.10 Clotting Studies 5.10.1 Fibrinogen Levels 5.10.2 Prothrombin Time (PT) 5.10.3 Partial Thromboplastin Time (PTT) 5.11 Polymerase Chain Reaction (PCR) Method 5.12 Nucleic Acid Testing 5.13 Mass Spectroscopy 5.14 Point-of-Care Testing 6 Global Blood Stream Infection Testing Market, By Product 6.1 Introduction 6.2 Reagents 6.3 Instruments 6.4 Other Products 7 Global Blood Stream Infection Testing Market, By Technology 7.1 Introduction 7.2 Non-Conventional Testing 7.3 Conventional Testing 8 Global Blood Stream Infection Testing Market, By Application 8.1 Introduction 8.2 Mycobacteria 8.3 Fungemia 8.4 Bacteremia 9 Global Blood Stream Infection Testing Market, By End User 9.1 Introduction 9.2 Hospital Laboratories 9.3 Reference Laboratories 9.4 Academic Research Laboratories 9.5 Independent Diagnostic Centers 9.6 Other End Users 10 Global Blood Stream Infection Testing Market, By Geography 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.2.3 Mexico 10.3 Europe 10.3.1 Germany 10.3.2 UK 10.3.3 Italy 10.3.4 France 10.3.5 Spain 10.3.6 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Australia 10.4.5 New Zealand 10.4.6 South Korea 10.4.7 Rest of Asia Pacific 10.5 South America 10.5.1 Argentina 10.5.2 Brazil 10.5.3 Chile 10.5.4 Rest of South America 10.6 Middle East & Africa 10.6.1 Saudi Arabia 10.6.2 UAE 10.6.3 Qatar 10.6.4 South Africa 10.6.5 Rest of Middle East & Africa 11 Key Developments 11.1 Agreements, Partnerships, Collaborations and Joint Ventures 11.2 Acquisitions & Mergers 11.3 New Product Launch 11.4 Expansions 11.5 Other Key Strategies 12 Company Profiling 12.1 Thermo Fisher Scientific Inc. 12.2 Siemens Healthcare 12.3 F. Hoffmann-La Roche Ag. 12.4 Danaher 12.5 Cepheid Inc 12.6 C. R. Bard, Inc. 12.7 Biomrieux Inc. 12.8 Becton, Dickinson And Company 12.9 Beckman Coulter Inc 12.10 Alere Inc. 12.11 Abbott Laboratories For more information about this report visit https://www.researchandmarkets.com/research/p...blood?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Infectious Disease Testing
